Abstract:1560 Objectives: We have been investigating a pretargeting approach in which an antibody conjugated with a phosphorodiamidate morpholino oligomer (MORF) is administered before a radiolabeled complementary MORF (i.e. cMORF). Having been successful using the antiCEA antibody MN14 in LS174T tumors pretargeted in this manner, we are now considering the anti-PMSA antibody 3C6 in LNCaP cells as well as other antibody/cell pairs for this application. However, successful pretargeting of tumor requires that the antitumor antibody be accessible on the cell surface to the radiolabeled effector. Accordingly, a simple and accurate method of measuring the internalization properties of each antitumor antibody/cell pair under consideration for pretargeting studies would be welcome. Methods: After confirming the specificity of the anti-PMSA antibody 3C6 for the PSMA positive LNCaP cells, a pretargeting study was performed in culture by incubating the cells with MORF-3C6 for different times before the addition of 99mTc-cMORF. In parallel, the cells were also incubated at the same dosage and for the same time periods under identical conditions with MORF-3C6 radiolabeled by hybridization with the 99mTc-cMORF. Comparison of the radioactivity on cells in the two studies provided a means of establishing the percentage of antibody internalized and therefore unavailable for binding to the 99mTc-cMORF. Results: Under the conditions of this study, the cellular accumulation of 99mTc-cMORF plateaued at 1.3% within 30 min in the cell pretargeting study, but the cell associated radioactivity of 99mTc-3C6 gradually increased reaching 4.2% at 5 h. The difference of 2.9% therefore represents a 70% loss of antibody accessibility due to internalization. Over time, the internalization increased roughly at about 0.6% per hour. The significant loss of antibody expression due to internalization could explain our unsuccessful pretargeting study using the 3C6 antibody in BALB/c mice bearing LNCaP xenografts. Conclusions: A novel approach for measuring internalization of antitumor antibodies has been described that will be useful in assessing antibody/cell pairs in connection with pretargeting. This approach obviates the need in the conventional approach to dissociate cell bound antibody under harsh conditions such as exposure to glycine or other acidic washes.

INTERNALIZATION OF RADIOLABELED MG SERIES MONOCLONAL ANTIBODIES AGAINST HUMAN GASTRIC CANCER

188Re-Labeled GX1 Dimer As a Novel Dual-Functional Probe Targeting TGM2 for Imaging and Antiangiogenic Therapy of Gastric Cancer

Accurate Determination of Internalization for Target Binding Antibody Using Papain Digestion and Flow Cytometry

In-vitro internalization and in-vivo tumor uptake of anti-EGFR monoclonal antibody LA22 in A549 lung cancer cells and animal model.

A Novel Method Measuring Internalization in Tumor Cells by Cell Pretargeting

Effect of Targeting Treatment of Mitomycin-C Immunoconjugate on Stomach Neoplasm

Comparative Biodistribution of Potential Anti-Glioblastoma Conjugates [111In]dtpa-Hegf and [111In]bz-Dtpa-hegf in Normal Mice

[Experimental Study of Radioimmunotherapy for Xenograft of Human Esophageal Carcinoma].

Novel Indium-111 Labeled Gastrin Peptide Analogues (Mg-Cl1-4): Synthesis and Quality Control

Radioimmunoimaging and Biodistribution of ~(131)I Labeled Anti-Cea Monoclonal Antibody C50 in Nude Mice Bearing Human Breast Carcinoma Xenografts

THE SPECIFIC PHOTODYNAMIC EFFECTS OF MONOCLONAL ANTIBODIES CONJUGATED WITH HEMATOPORPHYRIN DERIVATIVE ON GASTRIC CANCER IN VITRO AND IN VIVO

2P Molecular Imaging Evaluation of a Novel Claudin18.2 Specific Monoclonal Antibody Labeled with Radionuclide

Multiple-tumor binding specificity and high tumor uptake of monoclonal antibody 3H11

211 At labeling of a monoclonal antibody and its Fab fragment: Cytotoxicity on human gastric cancer cells and biodistribution in nude mice with tumor xenografts

Biodistribution and γ Imaging of ~(125)I-labeled Goat Anti-human IgG Polyclonal Antibody in Nude Mice Bearing Human Colon Cancer Xenografts

Effects of a 99Mtc-Labeled Murine Immunoglobulin M Antibody to CD15 Antigens on Human Granulocyte Membranes in Healthy Volunteers.

A Novel Pretargeting Method for Measuring Antibody Internalization in Tumor Cells

Tumor Targeting of 125I-Labeled Anti-Egfr Monoclonal Antibody LA22 in HT-29 Human Colon Cancer

Diverse metabolic response of cancer cells treated with a 213Bi-anti-EGFR-immunoconjugate

Biodistribution and Imaging of Radioiodinate Antihuman Tumor-derived IgG Light Chain Monoclonal Antibody in Nude Mice Bearing Tumor in Vivo

Astatine‐211 Labeling of a Monoclonal Antibody and Its Fab Fragment Synthesis, Immunoreactivity and Experimental Therapy